| JPM TAIWAN D (ACC) USD | RVI CHINA | 86,85% | 179,52% | 136,03% | 367,07% |
| T.ROWE US LARGE CAP GROWTH EQUITY FUND Q | RVI USA | 7,74% | 61,85% | 57,76% | 366,16% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 46,89% | 93,37% | 83,88% | 365,88% |
| JPM JAPAN EQUITY C (ACC) USD (HEDGED) | RVI JAPÓN | 22,16% | 90,81% | 92,26% | 365,85% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 46,86% | 93,42% | 84,12% | 365,41% |
| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) I-A1-ACC | RVI USA CRECIMIENTO | 7,30% | 61,98% | 68,61% | 364,96% |
| BANKINTER EE.UU. NASDAQ 100, FI R | RVI TECNOLOGÍA | 18,82% | 73,51% | 60,83% | 364,07% |
| T.ROWE US LARGE CAP GROWTH EQUITY FUND Q (GBP) | RVI USA | 7,75% | 61,76% | 57,61% | 362,27% |
| LORD ABBETT INNOVATION GROWTH FUND I USD CAP | RVI GLOBAL CRECIMIENTO | 1,59% | 74,09% | 45,33% | 361,95% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) P-ACC | RVI TECNOLOGÍA | 22,48% | 62,41% | 45,53% | 359,46% |
